Friday, November 1, 2024
spot_img

DFDS 2024 OUTLOOK LOWERED BY MARKET SLOWDOWN AND TRANSACTION TERMINATION

COMPANY ANNOUNCEMENT no. 77 – 1 November 2024
 
  • EBIT 2024 outlook range lowered to DKK 1.5-1.7bn from DKK 1.7-2.1bn
  • Adjusted free cash flow 2024 outlook is changed to around DKK 1.2bn from
    around DKK 1.5bn

DFDS’ EBIT outlook range for 2024 is revised following results below expectations driven by mainly a more widespread slowdown in Europe than previously expected as well as intensified competition in northern European land transport markets and the Mediterranean freight ferry market.

The current market conditions are expected to continue for the rest of the year whilst a rebound in activity was previously expected for the rest of the year.

The termination of the share purchase agreement to acquire the international transport network of Ekol Logistics, announced earlier today, may moreover in Q4 2024 entail some financial impact.

As a consequence of the above, the EBIT 2024 outlook range is lowered to DKK 1.5-1.7bn from previously DKK 1.7-2.1bn, and the outlook for the adjusted free cash flow is changed to around DKK 1.2bn from previously around DKK 1.5bn.

The revenue growth 2024 outlook is changed to 8-10% from previously 8-11% as revenue from Ekol Logistics was previously included in the revenue outlook.

DFDS’ Q3 2024 interim report will be released on 7 November 2024 at around 7.30am CET.

Contact

Torben Carlsen, CEO +45 33 42 32 01

Karen Boesen, CFO +45 20 58 58 40

Søren Brøndholt Nielsen, IR +45 33 42 33 59

Dennis Kjærsgaard, Media +45 42 30 38 47


About DFDS

We operate a transport network in and around Europe with an annual revenue of DKK 28bn and 14,000 full-time employees.

We move goods in trailers by ferry, road & rail, and we offer complementary and related transport and logistics solutions.

We also move car and foot passengers on short sea and overnight ferry routes.

DFDS was founded in 1866 and headquartered and listed in Copenhagen.

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachment

  • DFDS_NO_77_01_11_2024_OUTLOOK_LOWERED

Powered by SlickText.com

Hot this week

Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy

On Thursday, ESSA Pharma Inc. EPIX announced its plans...

LyondellBasell Q3 Results Miss Estimates, Signals Softer Demand And Rising Costs For Q4

LyondellBasell Industries N.V. LYB shares are trading lower after...

JPMorgan To Pay Investors $151 Million After SEC Flags ‘Various Law Violations’

The U.S. Securities and Exchange Commission (SEC) announced Thursday...

Topics

spot_img

Related Articles

Popular Categories

spot_img